Vinogradova found that long-term using of NSAIDs and cyclooxygenase-2 (COX-2) inhibitors can reduce the risk of developing colorectal cancer through a large sample of clinical case-control analysis [27]. The gene discussed is PTGS2; the disease is colorectal cancer.